Savolitinib
3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
Molecular Identity
Savolitinib
3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
PubChem CID: 68289010
Savolitinib is a member of the class of triazolopyrazines that is 1H-[1,2,3]triazolo[4,5-b]pyrazine substituted by (1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl and 1-methyl-1H-pyrazol-4-yl groups at positions 1 and 6, respectively. It is a highly selective MET tyrosine kinase inhibitor that is approved in China for advanced NSCLC with MET exon 14 skipping mutations. It has a role as an antineoplastic agent and a c-Met tyrosine kinase inhibitor. It is a member of pyrazoles, an imidazopyridine and a triazolopyrazine.
2D Structure
Properties
C17H15N9
Molecular Formula
345.40
Molecular Weight
g/mol
345.1450
Exact Mass
Da
1.5
XLogP
Drug-like (Lipinski: < 5)
91.6
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
6
H-Bond Acceptors
505
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
SavolitinibVolitinib1313725-88-0HMPL-504AZD-6094AZD6094HMPL504savolitinibum2A2DA6857RAZD 60943-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazineDTXSID8011110161H-1,2,3-Triazolo(4,5-b)pyrazine, 1-((1S)-1-imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo[4,5-b]pyrazine1-((1S)-1-Imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo(4,5-b)pyrazine
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Savolitinib
Loading drug network...